Regennera
Company

Last deal

$50K

Amount

Pre-Seed

Stage

13.06.2017

Date

1

all rounds

$50K

Total amount

General

About Company
Regennera is developing a load-bearing synthetic bone graft that stimulates new bone and blood vessel growth.

Industry

Sector :

Subsector :

Also Known As

Regennera Therapeutics

Number of employees

Company Type

For Profit

Last funding type

Pre-Seed

IPO status

Private

Description

The company is working on an all-in-one fracture repair device that combines a composite polymeric/hydroxyapatite structural element with cells from the patient's bone marrow. This innovative approach, based on intellectual property from Rutgers University, aims to promote simultaneous bone and vasculature regeneration, mimicking the essential elements required for proper bone regrowth.
Contacts